Glucocorticoids and macrophage migration inhibitory factor (MIF) are neuroendocrine modulators of inflammation and neuropathic pain after spinal cord injury.

[1]  M. Hautzinger,et al.  Depression, Posttraumatic Stress, and Risk Factors Following Spinal Cord Injury , 2014, International Journal of Behavioral Medicine.

[2]  P. New,et al.  Preliminary investigation into subjective well-being, mental health, resilience, and spinal cord injury , 2013, The journal of spinal cord medicine.

[3]  Ruchir R. Shah,et al.  Deep Sequencing Identification of Novel Glucocorticoid-Responsive miRNAs in Apoptotic Primary Lymphocytes , 2013, PloS one.

[4]  T. Saksida,et al.  The role of endogenous glucocorticoids in glucose metabolism and immune status of MIF-deficient mice. , 2013, European journal of pharmacology.

[5]  M. Nash,et al.  Autonomic Dysreflexia Causes Chronic Immune Suppression after Spinal Cord Injury , 2013, The Journal of Neuroscience.

[6]  C. Metz,et al.  Pilot study: elevated circulating levels of the proinflammatory cytokine macrophage migration inhibitory factor in patients with chronic spinal cord injury. , 2013, Archives of physical medicine and rehabilitation.

[7]  R. Sapolsky,et al.  Glucocorticoid Signaling in Myeloid Cells Worsens Acute CNS Injury and Inflammation , 2013, The Journal of Neuroscience.

[8]  J. Cidlowski,et al.  The five Rs of glucocorticoid action during inflammation: ready, reinforce, repress, resolve, and restore , 2013, Trends in Endocrinology & Metabolism.

[9]  M. Vijayan,et al.  Role of glucocorticoid in developmental programming: evidence from zebrafish. , 2013, General and comparative endocrinology.

[10]  Dov B. Lerman-Sinkoff,et al.  Macrophage migration inhibitory factor acts as a neurotrophin in the developing inner ear , 2012, Development.

[11]  J. Cidlowski,et al.  Glucocorticoids regulate arrestin gene expression and redirect the signaling profile of G protein-coupled receptors , 2012, Proceedings of the National Academy of Sciences.

[12]  E. Walters,et al.  Nociceptors as chronic drivers of pain and hyperreflexia after spinal cord injury: an adaptive-maladaptive hyperfunctional state hypothesis , 2012, Front. Physio..

[13]  Jessica K. Alexander,et al.  Macrophage migration inhibitory factor (MIF) is essential for inflammatory and neuropathic pain and enhances pain in response to stress , 2012, Experimental Neurology.

[14]  N. Finnerup,et al.  Spinal Cord Injury Pain: Mechanisms and Management , 2012, Current Pain and Headache Reports.

[15]  G. Rodríguez-Vega,et al.  Acute adrenal insufficiency in cervical spinal cord injury. , 2012, World neurosurgery.

[16]  Zhen Yan,et al.  The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission , 2011, Nature Reviews Neuroscience.

[17]  Jie Yang,et al.  Macrophage migration inhibitory factor activates cyclooxygenase 2–prostaglandin E2 in cultured spinal microglia , 2011, Neuroscience Research.

[18]  P. Fagone,et al.  Parkinson's disease is associated with increased serum levels of macrophage migration inhibitory factor. , 2011, Cytokine.

[19]  Ashish B. Shah,et al.  Complex regional pain syndrome. , 2011, Foot and ankle clinics.

[20]  Maija E. Rossi,et al.  Disease-associated inflammatory biomarker profiles in blood in different subtypes of multiple sclerosis: Prospective clinical and MRI follow-up study , 2011, Journal of Neuroimmunology.

[21]  Chengjie Xiong,et al.  Multiplexed Immunoassay Panel Identifies Novel CSF Biomarkers for Alzheimer's Disease Diagnosis and Prognosis , 2011, PloS one.

[22]  E. Hall.  Antioxidant Therapies for Acute Spinal Cord Injury , 2011, Neurotherapeutics.

[23]  J. Obata,et al.  High plasma levels of macrophage migration inhibitory factor are associated with adverse long-term outcome in patients with stable coronary artery disease and impaired glucose tolerance or type 2 diabetes mellitus. , 2010, Atherosclerosis.

[24]  T. Kaneko,et al.  Serum macrophage migration inhibitory factor reflects adrenal function in the hypothalamo-pituitary-adrenal axis of septic patients: an observational study , 2009, BMC infectious diseases.

[25]  R. Sapolsky,et al.  The Stressed CNS: When Glucocorticoids Aggravate Inflammation , 2009, Neuron.

[26]  J. Cidlowski,et al.  Mechanisms Generating Diversity in Glucocorticoid Receptor Signaling , 2009, Annals of the New York Academy of Sciences.

[27]  J. Bernhagen,et al.  A functional heteromeric MIF receptor formed by CD74 and CXCR4 , 2009, FEBS letters.

[28]  Jessica K. Alexander,et al.  Stress exacerbates neuropathic pain via glucocorticoid and NMDA receptor activation , 2009, Brain, Behavior, and Immunity.

[29]  F. Jessen,et al.  Macrophage migration inhibitory factor in mild cognitive impairment and Alzheimer's disease. , 2009, Journal of psychiatric research.

[30]  Katsunori Yoshinaga,et al.  Deletion of macrophage migration inhibitory factor attenuates neuronal death and promotes functional recovery after compression-induced spinal cord injury in mice , 2009, Acta Neuropathologica.

[31]  J. Sweatt,et al.  Deletion of ERK2 Mitogen-Activated Protein Kinase Identifies Its Key Roles in Cortical Neurogenesis and Cognitive Function , 2008, The Journal of Neuroscience.

[32]  F. Nicoletti,et al.  Macrophage migration inhibitory factor (MIF) is necessary for progression of autoimmune diabetes mellitus , 2008, Journal of cellular physiology.

[33]  D. Ray,et al.  Cunning factor: macrophage migration inhibitory factor as a redox‐regulated target , 2008, Immunology and cell biology.

[34]  C. Woolf,et al.  The neuropathic pain triad: neurons, immune cells and glia , 2007, Nature Neuroscience.

[35]  P. Popovich,et al.  Impaired antibody synthesis after spinal cord injury is level dependent and is due to sympathetic nervous system dysregulation , 2007, Experimental Neurology.

[36]  Shuxing Wang,et al.  Central glucocorticoid receptors regulate the upregulation of spinal cannabinoid-1 receptors after peripheral nerve injury in rats , 2007, Pain.

[37]  E. Dahl,et al.  Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity , 2007, Oncogene.

[38]  M. Toborek,et al.  Macrophage migration inhibitory factor induces cell death and decreases neuronal nitric oxide expression in spinal cord neurons , 2006, Neuroscience.

[39]  R. Ransohoff,et al.  Alterations in the oligodendrocyte lineage, myelin, and white matter in adult mice lacking the chemokine receptor CXCR2 , 2006, Glia.

[40]  L. Leng,et al.  CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex. , 2006, Immunity.

[41]  J. Vincent,et al.  EFFECTS OF DEXAMETHASONE ON MACROPHAGE MIGRATION INHIBITORY FACTOR PRODUCTION IN SEPSIS , 2006, Shock.

[42]  J. Bernhagen,et al.  Rapid and transient activation of the ERK MAPK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on JAB1/CSN5 and Src kinase activity. , 2006, Cellular signalling.

[43]  J. Deleo.  Basic science of pain. , 2006, The Journal of bone and joint surgery. American volume.

[44]  Shuxing Wang,et al.  Downregulation of spinal glutamate transporter EAAC1 followingnerve injury is regulated by central glucocorticoid receptors in rats , 2006, Pain.

[45]  I. Takasaki,et al.  Effects of glucocorticoid receptor antagonists on allodynia and hyperalgesia in mouse model of neuropathic pain. , 2005, European journal of pharmacology.

[46]  F. Nicoletti,et al.  Critical role of macrophage migration inhibitory factor activity in experimental autoimmune diabetes. , 2005, Endocrinology.

[47]  S. McMahon,et al.  Role of the Immune system in chronic pain , 2005, Nature Reviews Neuroscience.

[48]  M. Jensen,et al.  Chronic pain in individuals with spinal cord injury: a survey and longitudinal study , 2005, Spinal Cord.

[49]  Shuxing Wang,et al.  Central Glucocorticoid Receptors Modulate the Expression and Function of Spinal NMDA Receptors after Peripheral Nerve Injury , 2005, The Journal of Neuroscience.

[50]  S. Rivest,et al.  Glucocorticoids: Protectors of the Brain during Innate Immune Responses , 2004, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[51]  Yi Dai,et al.  Role of Mitogen-Activated Protein Kinase Activation in Injured and Intact Primary Afferent Neurons for Mechanical and Heat Hypersensitivity after Spinal Nerve Ligation , 2004, The Journal of Neuroscience.

[52]  Shuxing Wang,et al.  Expression of Central Glucocorticoid Receptors after Peripheral Nerve Injury Contributes to Neuropathic Pain Behaviors in Rats , 2004, The Journal of Neuroscience.

[53]  T. Rudy,et al.  Effects of a stress-reduction program on psychological function, pain, and physical function of systemic lupus erythematosus patients: a randomized controlled trial. , 2004, Arthritis and rheumatism.

[54]  S. Onodera,et al.  Up-regulation of macrophage migration-inhibitory factor expression after compression-induced spinal cord injury in rats , 2004, Acta Neuropathologica.

[55]  J. Bernhagen,et al.  Stabilization of Atherosclerotic Plaques by Blockade of Macrophage Migration Inhibitory Factor After Vascular Injury in Apolipoprotein E–Deficient Mice , 2004, Circulation.

[56]  T. Calandra,et al.  Macrophage migration inhibitory factor: a regulator of innate immunity , 2003, Nature Reviews Immunology.

[57]  L. Leng,et al.  MIF Signal Transduction Initiated by Binding to CD74 , 2003, The Journal of experimental medicine.

[58]  F. Porreca,et al.  Neurotrophic factors as novel therapeutics for neuropathic pain , 2003, Nature Reviews Drug Discovery.

[59]  M. Le Moal,et al.  The Glucocorticoid Receptor as a Potential Target to Reduce Cocaine Abuse , 2003, The Journal of Neuroscience.

[60]  S. Rutkowski,et al.  A longitudinal study of the prevalence and characteristics of pain in the first 5 years following spinal cord injury , 2003, Pain.

[61]  Yi Dai,et al.  Differential Activation of Extracellular Signal-Regulated Protein Kinase in Primary Afferent Neurons Regulates Brain-Derived Neurotrophic Factor Expression after Peripheral Inflammation and Nerve Injury , 2003, The Journal of Neuroscience.

[62]  M. Denkinger,et al.  In Vivo Blockade of Macrophage Migration Inhibitory Factor Ameliorates Acute Experimental Autoimmune Encephalomyelitis by Impairing the Homing of Encephalitogenic T Cells to the Central Nervous System , 2003, The Journal of Immunology.

[63]  Hiroyuki Kato,et al.  Role of Macrophage Migration Inhibitory Factor (MIF) in Peripheral Nerve Regeneration: Anti-MIF Antibody Induces Delay of Nerve Regeneration and the Apoptosis of Schwann Cells , 2002, Molecular medicine.

[64]  A. Markus,et al.  Raf and Akt Mediate Distinct Aspects of Sensory Axon Growth , 2002, Neuron.

[65]  M. Jensen,et al.  Catastrophizing is associated with pain intensity, psychological distress, and pain-related disability among individuals with chronic pain after spinal cord injury , 2002, Pain.

[66]  P. Gregersen,et al.  A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis , 2002, Genes and Immunity.

[67]  J. Bernhagen,et al.  Expression of Macrophage Migration Inhibitory Factor in Different Stages of Human Atherosclerosis , 2002, Circulation.

[68]  J. Bernhagen,et al.  Macrophage migration inhibitory factor (MIF): mechanisms of action and role in disease. , 2002, Microbes and infection.

[69]  D. Gemsa,et al.  Borna disease virus‐induced accumulation of macrophage migration inhibitory factor in rat brain astrocytes is associated with inhibition of macrophage infiltration , 2002, Glia.

[70]  O. Kretz,et al.  Corticosteroid receptors in the brain: gene targeting studies , 2002, Brain Research Bulletin.

[71]  J. Barrett,et al.  Cytokine gene polymorphisms and susceptibility to juvenile idiopathic arthritis , 2001 .

[72]  M. Davies,et al.  Glucocorticoid Inhibition of Neuropathic Hyperalgesia and Spinal Fos Expression , 2001, Anesthesia and analgesia.

[73]  J. Bernhagen,et al.  Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1 , 2000, Nature.

[74]  R. Bucala.  Signal transduction: A most interesting factor , 2000, Nature.

[75]  R. Atkins,et al.  Expression of macrophage migration inhibitory factor in human glomerulonephritis. , 2000, Kidney international.

[76]  M. Taniguchi,et al.  Deficiency of the macrophage migration inhibitory factor gene has no significant effect on endotoxaemia , 2000, Immunology.

[77]  C. Woolf,et al.  Nociceptive-specific activation of ERK in spinal neurons contributes to pain hypersensitivity , 1999, Nature Neuroscience.

[78]  Chung-Yuan Hsu,et al.  Glucocorticoid Receptor Expression in the Spinal Cord after Traumatic Injury in Adult Rats , 1999, The Journal of Neuroscience.

[79]  Tina Peng,et al.  Sustained Mitogen-activated Protein Kinase (MAPK) and Cytoplasmic Phospholipase A2 Activation by Macrophage Migration Inhibitory Factor (MIF) , 1999, The Journal of Biological Chemistry.

[80]  D. Tracey,et al.  Hyperalgesia due to nerve damage: role of nerve growth factor , 1999, Pain.

[81]  E. Vershinina,et al.  Pain sensitivity in chronic psychoemotional stress in humans , 1999, Neuroscience and Behavioral Physiology.

[82]  R. Atkins,et al.  Reversal of Established Rat Crescentic Glomerulonephritis by Blockade of Macrophage Migration Inhibitory Factor (MIF): Potential Role of MIF in Regulating Glucocorticoid Production , 1998, Molecular medicine.

[83]  R. Bucala,et al.  Involvement of macrophage migration inhibitory factor in the evolution of rat adjuvant arthritis. , 1998, Arthritis and rheumatism.

[84]  R. Atkins,et al.  MIF Expression in the Rat Brain: Implications for Neuronal Function , 1998, Molecular medicine.

[85]  R. Holmdahl,et al.  Macrophage migration inhibitory factor is involved in the pathogenesis of collagen type II-induced arthritis in mice. , 1997, Journal of immunology.

[86]  A. Malmberg,et al.  Efficacy of spinal NMDA receptor antagonism in formalin hyperalgesia and nerve injury evoked allodynia in the rat. , 1997, The Journal of pharmacology and experimental therapeutics.

[87]  J. Bernhagen,et al.  Localization of Macrophage Migration Inhibitory Factor (MIF) to Secretory Granules within the Corticotrophic and Thyrotrophic Cells of the Pituitary Gland , 1995, Molecular medicine.

[88]  J. Bernhagen,et al.  MIF as a glucocorticoid-induced modulator of cytokine production , 1995, Nature.

[89]  K. Tracey,et al.  MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia , 1993, Nature.

[90]  B. Bloom,et al.  Mechanism of a Reaction in Vitro Associated with Delayed-Type Hypersensitivity , 1966, Science.

[91]  R. Atkins,et al.  Urine macrophage migration inhibitory factor reflects the severity of renal injury in human glomerulonephritis. , 2002, Journal of the American Society of Nephrology : JASN.

[92]  J. Cruse,et al.  Immune system-neuroendocrine dysregulation in spinal cord injury , 1996, Immunologic research.